Legal Opinion
In Re Fosamax Products Liability Litigation
District Court, S.D. New York
Decided January 27, 2010No. 1:06-mj-01789PublishedCited by 12 opinions
1Opinion of the Court
OPINION & ORDER
JOHN F. KEENAN, District Judge 1 .
This case was selected by Merck Sharp & Dohme Corporation (“Merck” or “Defendant”) as a bellwether case in this multi-district products liability litigation concerning the osteoporosis drug Fosamax. Before the Court is defendant Merck’s motion for summary judgment seeking the dismissal of all claims filed by plaintiff Louise H. Maley (“Maley” or “Plaintiff’). For the following reasons, Merck’s motion is denied.
I. BACKGROUND
A. Fosamax and ONJ 2
Fosamax is an oral bisphosphonate manufactured by Merck for the treatment of osteoporosis. Plaintiff…
2Cases cited19 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- General Electric Co. v. JoinerSupreme Court of the United States · 1997
- Nikitas Amorgianos v. National Railroad Passenger CorporationCourt of Appeals for the Second Circuit · 2002
14 more not listed; retrieve them via the Exa API.
3Cited by12 opinions
- Deutsch Ex Rel. Estate of Deutsch v. Novartis Pharmaceuticals Corp.District Court, E.D. New York · 2011
- I.M. v. United StatesDistrict Court, S.D. Illinois · 2019
- Davids v. Novartis Pharmaceuticals Corp.District Court, E.D. New York · 2012
- Bee v. Novartis Pharmaceuticals Corp.District Court, E.D. New York · 2014
- Derienzo v. Metropolitan Transportation AuthorityDistrict Court, S.D. New York · 2010
7 more not listed; retrieve them via the Exa API.